T cells from burn-injured mice demonstrate a loss of sensitivity to glucocorticoids

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 2, 2010, Pages

  D'Elia, Michele ^a   Patenaude, Julie ^a   Dupras, Charles ^a   Bernier, Jacques ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Mitogen activated protein kinase; Resistance; T lymphocyte

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD3 ANTIBODY; CD4 ANTIGEN; CD44V ANTIGEN; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY CD3; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD3 ANTIGEN; FLUORESCEIN DERIVATIVE; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING COMPETITION; BODY SURFACE; BURN; C57BL 6 MOUSE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THERMAL INJURY; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CYTOLOGY; DRUG EFFECT; DRUG RESISTANCE; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SPLEEN; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; BLOTTING, WESTERN; BURNS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DRUG RESISTANCE; FLUORESCEINS; GLUCOCORTICOIDS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; RECEPTORS, GLUCOCORTICOID; SPLEEN; SUCCINIMIDES; T-LYMPHOCYTES;

EID: 77954935957     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00084.2010     Document Type: Article

References (48)

1. Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest 134: 394-401, 2008.
2. Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns 20: 487-490, 1994.
3. Batuman OA, Ferrero AP, Diaz A, Berger B, Pomerantz RJ. Glucocorticoid-mediated inhibition of interleukin-2 receptor-alpha and -beta subunit expression by human T cells. Immunopharmacology 27: 43-55, 1994.
4. Berenson LS, Yang J, Sleckman BP, Murphy TL, Murphy KM. Selective requirement of p38alpha MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses. J Immunol 176: 4616-4621, 2006.
5. Biola A, Lefebvre P, Perrin-Wolff M, Sturm M, Bertoglio J, Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol Endocrinol 15: 1062-1076, 2001.
6. Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 34: 14-21, 2005. (Pubitemid 40445053)
7. Choudhry MA, Ren X, Romero A, Kovacs EJ, Gamelli RL, Sayeed MM. Combined alcohol and burn injury differentially regulate P-38 and ERK activation in mesenteric lymph node T cell. J Surg Res 121: 62-68, 2004.
8. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271: 6497-6501, 1996.
9. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 272: 15023-15027, 1997.
10. D'Elia M, Patenaude J, Bernier J. Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice. Am J Physiol Endocrinol Metab 296: E97-E104, 2009.
11. D'Elia M, Patenaude J, Dupras C, Bernier J. Burn injury induces the expression of cystine/glutamate transporter [x(c)(-)] in mouse T cells. Immunol Lett 125: 137-144, 2009.
12. D'Elia M, Patenaude J, Hamelin C, Garrel DR, Bernier J. Corticosterone binding globulin regulation and thymus changes after thermal injury in mice. Am J Physiol Endocrinol Metab 288: E852-E860, 2005.
13. Da Silva J, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272: 28373-28380, 1997.
14. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 20: 55-72, 2002.
15. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024: 138-146, 2004.
16. Esposito F, Cuccovillo F, Morra F, Russo T, Cimino F. DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim Biophys Acta 1260: 308-314, 1995.
17. Faunce DE, Gregory MS, Kovacs EJ. Glucocorticoids protect against suppression of T cell responses in a murine model of acute ethanol exposure and thermal injury by regulating IL-6. J Leukoc Biol 64: 724-732, 1998.
18. Fazal N, Choudhry MA, Sayeed MM. Inhibition of T cell MAPKs (Erk1/2, p38) with thermal injury is related to down-regulation of Ca2+ signaling. Biochim Biophys Acta 1741: 113-119, 2005.
19. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann NY Acad Sci 1024: 124-137, 2004. (Pubitemid 38879597)
20. Fukuzuka K, Edwards 3rd CK, Clare-Salzer M, Copeland 3rd EM, Moldawer LL, Mozingo DW. Glucocorticoid and Fas ligand induced mucosal lymphocyte apoptosis after burn injury. J Trauma 49: 710-716, 2000.
21. Fukuzuka K, Edwards 3rd CK, Clare-Salzler M, Copeland 3rd EM, Moldawer LL, Mozingo DW. Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp Physiol 278: R1005-R1018, 2000.
22. Goleva E, Kisich KO, Leung DY. A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol 169: 5934-5940, 2002.
23. Hunt JP, Hunter CT, Brownstein MR, Giannopoulos A, Hultman CS, deSerres S, Bracey L, Frelinger J, Meyer AA. The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury. J Surg Res 80: 243-251, 1998.
24. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109: 649-657, 2002.
25. Jobin N, Garrel DR, Champoux J, Bernier j. Improved immune functions with administration of a low-fat diet in a burn animal model. Cell Immunol 206: 71-84, 2000.
26. Jung-Testas I, Baulieu EE. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Exp Cell Res 147: 177-182, 1983.
27. Kavanagh EG, Kelly JL, Lyons A, Soberg CC, Mannick JA, Lederer JA. Burn injury primes naive CD4+ T cells for an augmented T-helper 1 response. Surgery 124: 269-277, 1998.
28. Lacroix A, Bonnard GD, Lippman ME. Modulation of glucocorticoid receptors by mitogenic stimuli, glucocorticoids and retinoids in normal human cultured T cells. J Steroid Biochem 21: 73-80, 1984. (Pubitemid 14090492)
29. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22: 7802-7811, 2002.
30. Li X, Rana SN, Kovacs EJ, Gamelli RL, Chaudry IH, Choudhry MA. Corticosterone suppresses mesenteric lymph node T cells by inhibiting p38/ERK pathway and promotes bacterial translocation after alcohol and burn injury. Am J Physiol Regul Integr Comp Physiol 289: R37-R44, 2005.
31. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 135: 181-193, 2009.
32. Nakanishi T, Nishi Y, Sato EF, Ishii M, Hamada T, Inoue M. Thermal injury induces thymocyte apoptosis in the rat. J Trauma 44: 143-148, 1998.
33. O'Sullivan AW, Wang JH, Redmond HP. NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J Surg Res 2008.
34. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J. Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 77: 141-150, 2005. (Pubitemid 40315047)
35. Planey SL, Litwack G. Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun 279: 307-312, 2000.
36. Polito A, Aboab J, Annane D. The hypothalamic pituitary adrenal axis in sepsis. Novartis Found Symp 280: 182-99; discussion 199-203, 2007.
37. Pruett SB, Fan R, Zheng Q. Characterization of glucocorticoid receptor translocation, cytoplasmic IkappaB, nuclear NFkappaB, and activation of NFkappaB in T lymphocytes exposed to stress-inducible concentrations of corticosterone in vivo. Int Immunopharmacol 3: 1-16, 2003.
38. Randazzo B, Hirschberg T, Hirschberg H. Inhibition of the antigen activated T cell response by methylprednisolone is caused by inhibition of interleukin-2 (IL-2) production. Int J Immunopharmacol 6: 419-423, 1984.
39. Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, Su MS, Penix LA, Davis RJ, Flavell RA. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 17: 2817-2829, 1998.
40. Salmon RA, Foltz IN, Young PR, Schrader JW. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol 159: 5309-5317, 1997.
41. Sandi C, Cambronero JC, Borrell J, Guaza C. Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation. Neuroendocrinology 56: 574-581, 1992.
42. Song GY, Chung CS, Chaudry IH, Ayala A. Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. J Surg Res 91: 141-146, 2000. (Pubitemid 30445588)
43. Song GY, Chung CS, Chaudry IH, Ayala A. MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol Cell Physiol 281: C662-C669, 2001.
44. Szatmary Z, Garabedian MJ, Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem 279: 43708-43715, 2004.
45. Tanaka H, Makino Y, Okamoto K, Iida T, Yan K, Yoshikawa N. Redox regulation of the glucocorticoid receptor. Antioxid Redox Signal 1: 403-423, 1999.
46. Veiopoulou C, Kogopoulou O, Tzakos E, Mavrothalassitis G, Mitsias D, Karafoulidou A, Paliogianni F, Moutsopoulos HM, Thyphronitis G. IL-2 and IL-10 production by human CD4+T cells is differentially regulated by p38: mode of stimulation-dependent regulation of IL-2. Neuroimmunomodulation 11: 199-208, 2004.
47. Wang Z, Frederick J, Garabedian MJ. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem 277: 26573-26580, 2002.
48. Zedler S, Bone RC, Baue AE, von Donnersmarck GH, Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 27: 66-72, 1999. (Pubitemid 29052816)